Anti-LNX1 antibodies are used in the immunodetection of the protein ligand of numb-protein X 1. In humans, the canonical protein has a reported length of 728 amino acid residues and a mass of 80.6 kDa. Its subcellular localization is in the cytoplasm. Up to 2 different isoforms have been reported for this protein. It is found to be expressed in the heart, placenta, kidney, pancreas and brain. LNX1 is known to be involved with protein ubiquitination. Synonyms for this target antigen include PDZ domain-containing ring finger protein 2, RING-type E3 ubiquitin transferase LNX, ligand of numb-protein X 1, E3 ubiquitin protein ligase, and E3 ubiquitin-protein ligase LNX. LNX1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some LNX1 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunofluorescence is also a common application.